Radiotherapeutic options for symptom control in breast cancer

Birgitt Van Oorschot; Gabriele Beckmann; Wolfgang Schulze; Dirk Rades; Petra Feyer

doi:10.1159/000324564

Radiotherapeutic options for symptom control in breast cancer

Birgitt Van Oorschot^*, Gabriele Beckmann, Wolfgang Schulze, Dirk Rades, Petra Feyer

^*Corresponding author for this work

Clinic of Radiotherapy

University of Würzburg

11 Citations (Scopus)

Abstract

The majority of breast cancer patients will require radiation therapy at some time during the course of their disease. An estimated 30-50% of all radiation treatments are of palliative nature, either to alleviate symptoms or prophylactic to prevent deterioration of quality of life due to locally progressive disease. Radiotherapy is a locally effective tool, and typically causes no systemic and mostly mild acute side effects. The following article provides an overview of options and decision-making in palliative radiotherapy for symptom control.

Original language	English
Journal	Breast Care
Volume	6
Issue number	1
Pages (from-to)	14-19
Number of pages	6
ISSN	1661-3791
DOIs	https://doi.org/10.1159/000324564
Publication status	Published - 02.2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1159/000324564

Cite this

@article{4e254b08042f409aa57a4e68ac913833,

title = "Radiotherapeutic options for symptom control in breast cancer",

abstract = "The majority of breast cancer patients will require radiation therapy at some time during the course of their disease. An estimated 30-50\% of all radiation treatments are of palliative nature, either to alleviate symptoms or prophylactic to prevent deterioration of quality of life due to locally progressive disease. Radiotherapy is a locally effective tool, and typically causes no systemic and mostly mild acute side effects. The following article provides an overview of options and decision-making in palliative radiotherapy for symptom control.",

author = "\{Van Oorschot\}, Birgitt and Gabriele Beckmann and Wolfgang Schulze and Dirk Rades and Petra Feyer",

year = "2011",

month = feb,

doi = "10.1159/000324564",

language = "English",

volume = "6",

pages = "14--19",

journal = "Breast Care",

issn = "1661-3791",

publisher = "S. Karger AG",

number = "1",

}

TY - JOUR

T1 - Radiotherapeutic options for symptom control in breast cancer

AU - Van Oorschot, Birgitt

AU - Beckmann, Gabriele

AU - Schulze, Wolfgang

AU - Rades, Dirk

AU - Feyer, Petra

PY - 2011/2

Y1 - 2011/2

N2 - The majority of breast cancer patients will require radiation therapy at some time during the course of their disease. An estimated 30-50% of all radiation treatments are of palliative nature, either to alleviate symptoms or prophylactic to prevent deterioration of quality of life due to locally progressive disease. Radiotherapy is a locally effective tool, and typically causes no systemic and mostly mild acute side effects. The following article provides an overview of options and decision-making in palliative radiotherapy for symptom control.

AB - The majority of breast cancer patients will require radiation therapy at some time during the course of their disease. An estimated 30-50% of all radiation treatments are of palliative nature, either to alleviate symptoms or prophylactic to prevent deterioration of quality of life due to locally progressive disease. Radiotherapy is a locally effective tool, and typically causes no systemic and mostly mild acute side effects. The following article provides an overview of options and decision-making in palliative radiotherapy for symptom control.

UR - https://www.scopus.com/pages/publications/79952269116

U2 - 10.1159/000324564

DO - 10.1159/000324564

M3 - Scientific review articles

AN - SCOPUS:79952269116

SN - 1661-3791

VL - 6

SP - 14

EP - 19

JO - Breast Care

JF - Breast Care

IS - 1

ER -

Radiotherapeutic options for symptom control in breast cancer

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this